Amyotrophic Lateral Sclerosis Genetic Studies

@article{He2015AmyotrophicLS,
  title={Amyotrophic Lateral Sclerosis Genetic Studies},
  author={Ji He and Marie Mangelsdorf and Dongsheng Fan and Perry F. Bartlett and Matthew A. Brown},
  journal={The Neuroscientist},
  year={2015},
  volume={21},
  pages={599 - 615}
}
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of obscure etiology. Multiple genetic studies have been conducted to advance our understanding of the disease, employing a variety of techniques such as linkage mapping in families, to genome-wide association studies and sequencing based approaches such as whole exome sequencing and whole genome sequencing and a few epigenetic analyses. While major progress has been made, the majority of the genetic variation involved in ALS is… 
Clinical and genetic basis of familial amyotrophic lateral sclerosis.
TLDR
There is a direct correlation between the profile of the mutated genes in sporadic and familial forms, highlighting the main role of C9orf72 gene in the clinical forms associated with frontotemporal dementia spectrum.
A comprehensive review of amyotrophic lateral sclerosis
TLDR
This study provides a comprehensive review of ALS covering all aspects of the disease including epidemiology, comorbidities, environmental risk factor, molecular mechanism, genetic factors, symptoms, diagnostic, treatment, and even the available supplement and management.
Whole-exome sequencing in amyotrophic lateral sclerosis suggests NEK1 is a risk gene in Chinese
TLDR
While SOD1 is already recognised as an ALS-associated gene in Chinese, novel evidence for association of NEK1 with ALS in Chinese is provided, reporting variants in these genes not previously found in Europeans.
Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives
TLDR
Edaravone is a new FDA-approved medication that may slow the disease progression by 33% in a selected subgroup of ALS patients, and the recent data on masitinib, the role of enteral feeding, gene therapy, and stem cell therapy is discussed.
From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis
TLDR
The most significant contributions of omics technologies in unraveling the biological heterogeneity of ALS are discussed, highlighting how these approaches are revealing diagnostic, prognostic and therapeutic targets for future personalized interventions.
CHCHD10 mutations in patients with amyotrophic lateral sclerosis in Mainland China
TLDR
The findings support the major role of CHCHD10 in the frontotemporal dementia-amyotrophic lateral sclerosis disease spectrum and stress the importance of mitochondrial abnormalities in the pathogenesis of diseases in Asian cohorts.
Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.
TLDR
Accumulating evidence supports the concept that epigenetic-driven modifications, including altered chromatin remodelling events, RNA editing and non-coding RNA molecules, might shed light into the pathogenic mechanisms underlying sporadic/familiar ALS onset and/or severity to facilitate the identification of effective therapies, early diagnosis and potentially early-stage therapeutic interventions to increase the survival outcome of ALS patients.
Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement
TLDR
The current review discusses the main aspects related to ALS, such as the main genes involved, the most important molecular mechanisms that affect this pathology, its ocular involvement, and the possible usefulness of the retina as a biomarker.
The epidemiology of amyotrophic lateral sclerosis.
TLDR
An epidemiologic summary of personal and environmental risk factors shown to be related to the risk of disease is provided and a discussion of the most recent research initiatives is included.
Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta‐analysis
TLDR
The extent to which these associations may be causal is discussed, with further research recommended to strengthen the evidence on which determinations of causality may be based.
...
1
2
...

References

SHOWING 1-10 OF 123 REFERENCES
Familial amyotrophic lateral sclerosis, a historical perspective
  • T. Siddique, S. Ajroud‐Driss
  • Medicine
    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
  • 2011
TLDR
This article chronologically summarize the genetic breakthroughs in familial and sporadic ALS and depicts how it shaped the understanding of disease pathogenesis and the quest for rational therapies.
Exome sequencing to identify de novo mutations in sporadic ALS trios
TLDR
Se sequencing of exomes of ALS patients and unaffected parents found that amino acid–altering de novo mutations were enriched in genes encoding chromatin regulators, including the neuronal chromatin remodeling complex (nBAF) component SS18L1 (also known as CREST).
ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study
TLDR
A genetic variant in the inositol 1,4,5-triphosphate receptor 2 gene (ITPR2) is a strong candidate susceptibility gene for ALS because it is involved in glutamate-mediated neurotransmission, is one of the main regulators of intracellular calcium concentrations, and has an important role in apoptosis.
Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS
TLDR
This study has identified candidate genes for sporadic ALS, most notably CYP27A1, which is causal to cerebrotendinous xanthomatosis which can present as a clinical mimic of ALS with progressive upper motor neuron loss, making it a plausible susceptibility gene for ALS.
A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese.
TLDR
The results strongly suggest that ZNF 512B is an important positive regulator of TGF-β signaling and that decreased ZNF512B expression increases susceptibility to ALS.
Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study
TLDR
The data suggest the presence of a founder mutation for chromosome 9p21-linked ALS in the Finnish population, and the overlap with the risk haplotype recently reported for frontotemporal dementia provides further evidence of a shared genetic cause for these two neurodegenerative diseases.
Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis
TLDR
This study represents an initial identification of epigenetic regulatory mechanisms in sALS which may improve the understanding of sALS pathogenesis for the identification of biomarkers and new therapeutic targets.
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
TLDR
Neuronal cytoplasmic protein aggregation and defective RNA metabolism thus appear to be common pathogenic mechanisms involved in ALS and possibly in other neurodegenerative disorders.
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis.
TLDR
The findings of this GWAS suggest that ALS is more genetically and clinically heterogeneous than previously recognized.
An estimate of amyotrophic lateral sclerosis heritability using twin data
TLDR
The heritability of sporadic ALS was estimated as 0.61, and efforts to find causative genes should continue, and ALS has a high heritability.
...
1
2
3
4
5
...